Home » High-Quality Health Information » Health Topics » Metastatic Brain Tumors » Study: NCT00826241

| Print this page

• Home
• High-Quality
  Health Information
  • Health Topics
  • Health Resources
• Understanding Health Research
  • What is health research?
  • Is health research safe?
  • Is health research
    right for me?
• Health Research in Massachusetts
  • Search Ongoing Studies
  • Community-Engaged Research Projects
  • Community Health Centers

Title:	Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma
Status:	Recruiting participants
Conditions:	Brain Tumors; Spinal Cord Tumors
Interventions:	Drug: Temozolomide; Drug: Lapatinib
Institutions:	Dana-Farber Cancer Institute
Health Topics:	Metastatic Brain Tumors, Spinal Cord Tumors
View this study on ClinicalTrials.gov

Contact Information

---

© Community Connect to Research, 2012